Key points are not available for this paper at this time.
Low SMI and SMD are endemic across a range of cancer types and disease stage, challenging pre-existing dogma of the determinants of prevalence.
Share your take
Add a clinician perspective alongside expert commentary.
McGovern et al. (2021) studied this question.